Skip to main content

ALKEM · Alkem Laboratories Limited · Financials

5,110.00 INR -225.00 (-4.22%) At close · Nov 13
Volume · Nov 13 17.66K Avg daily vol (3M) 16.89K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
147.12B +13.5%
FY2026 Revenue FY2018–FY2026
Net Income
23.02B +6.3%
FY2026 Net Income FY2018–FY2026
Operating Cash Flow
19.63B +2.6%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2020 FY2019 FY2018
INR 156.32B 147.12B 129.65B 126.68B 115.99B 106.34B 83.44B 73.57B 64.31B
INR 4.38B 3.82B 3.57B 2.99B 3.1B 3.04B 2.53B 1.93B 1.43B
INR 2B 1.61B 1.22B 1.12B 1.07B 523.7M 650.6M 546.3M 553.3M
INR — — — 20.23B 13.05B 18.44B 12.6B 9.55B 9.26B
INR 8.81B 5.18B 3.11B 2.12B 2.98B 1.64B 1.1B 1.81B 2.88B
INR 20.68B 23.02B 21.65B 17.96B 9.84B 16.46B 11.27B 7.61B 6.31B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 26.1B in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.